Mettler-Toledo International Inc.
MTD NYSEHealthcare ★★★★★Latest Earnings
Date
Jul 30, 2026
ET
EPS Est.
10.85
EPS Actual
11.46
Revenue Est.
$1.03B
Revenue Actual
$1.03B
Next Earnings Report
Date
Nov 5, 2026 · Thu
Time
After-market
Fiscal Period
FY2026 Q3
EPS Est.
12.11
Revenue Est.
$1.07B
Company Overview
Mettler-Toledo International Inc. (ticker MTD) is listed on NYSE with a market cap of about $28.19B. Its next earnings report (FY2026 Q3) is expected on Nov 5, 2026 (ET), After-market, with consensus EPS of 12.11. In the last 15 reported quarters, EPS beat consensus estimates 14 times.
Actual EPS TrendRecently15Term · Feb 9, 2023 → Jul 30, 2026
Feb 9, 2023Range: 8.19 ~ 13.36Jul 30, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 30, 2026 | -- | 10.85 | 11.46 | $1.03B | $1.03B |
| May 7, 2026 | -- | 8.71 | 8.91 | $943.1M | $947.1M |
| Feb 5, 2026 | -- | 12.80 | 13.36 | $1.1B | $1.13B |
| Nov 6, 2025 | -- | 10.66 | 11.15 | $997.3M | $1.03B |
| Jul 31, 2025 | -- | 9.60 | 10.09 | $957.6M | $983.2M |
| May 1, 2025 | -- | 7.88 | 8.19 | $876.6M | $883.7M |
| Feb 6, 2025 | -- | 11.72 | 12.41 | $1.01B | $1.05B |
| Nov 8, 2024 | -- | 10.01 | 10.21 | $944.8M | $954.5M |
| Aug 1, 2024 | -- | 9.03 | 9.65 | $929.1M | $946.8M |
| May 9, 2024 | -- | 7.64 | Above forecast↑8.89 | $879.7M | $925.9M |
| Feb 8, 2024 | -- | 10.10 | 9.40 | $959.4M | $935M |
| Nov 9, 2023 | -- | 9.74 | 9.80 | $952M | $942.5M |
| Jul 27, 2023 | -- | 9.97 | 10.19 | $1.04B | $982.1M |
| May 4, 2023 | -- | 8.60 | 8.69 | $918.7M | $928.7M |
| Feb 9, 2023 | -- | 11.66 | 12.10 | $1.03B | $1.06B |
Original Filings (SEC)
8-K2026-08-03 ↗
10-Q2026-07-31 ↗
8-K2026-07-30 ↗
8-K2026-05-13 ↗
8-K2026-05-11 ↗
10-Q2026-05-08 ↗
8-K2026-05-07 ↗
10-K2026-02-06 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
